Delivery Order SPE2DX22D0049-SPE2D826FA1UF
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $28,224.74 to AmerisourceBergen Drug Corp on November 24, 2025, with completion scheduled for November 25, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,783.04 to AmerisourceBergen Drug Corp on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price, non-competitive delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $26,354.62 to AmerisourceBergen Drug Corp on November 10, 2025, with completion scheduled for November 12, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was issued with no set-aside...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $94,752.62 to AmerisourceBergen Drug Corp on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award was made on a competitive basis without set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $903,311.36 to AmerisourceBergen Drug Corp on November 15, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The delivery order is being performed...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $451,562.58 to AmerisourceBergen Drug Corp on October 30, 2025, with an ultimate completion date of October 31, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation and will be...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,746.40 to AmerisourceBergen Drug Corp on July 19, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively selected with no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $94,955.58 to AmerisourceBergen Drug Corp on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $639,440.58 to AmerisourceBergen Drug Corp on November 13, 2025, with an ultimate completion date of November 14, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999,999,999.00 ceiling and extends through December 2026....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $369,718.44 to AmerisourceBergen Drug Corp on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA1UFDelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $56,056 to AmerisourceBergen Drug Corp on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999 through December 2026. The award was competitively awarded with no set-aside designation, and performance will occur at the company's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. As a prime vendor under the DLA Troop Support Medical IDC, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's federal contract portfolio demonstrates extensive capability in delivering diverse medical products to support military healthcare programs worldwide, serving customers including the Defense Health Agency and the U.S. Coast Guard. This delivery order reflects the company's role within the broader Pharmaceutical Prime Vendor Global Program, which is designed to provide flexible and comprehensive pharmaceutical support to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.1k | 11/23/25 |